DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
One of the three most frequently documented copy number variations associated with autism spectrum disorder (ASD) is a 1q21.1 duplication that encompasses sequences encoding DUF1220 protein domains, the dosage of which we previously implicated in increased human brain size. Further, individuals with ASD frequently display accelerated brain growth and a larger brain size that is also associated with increased symptom severity. Given these findings, we investigated the relationship between DUF1220 copy number and ASD severity, and here show that in individuals with ASD (n = 170), the copy number (dosage) of DUF1220 subtype CON1 is highly variable, ranging from 56 to 88 copies following a Gaussian distribution. More remarkably, in individuals with ASD CON1 copy number is also linearly associated, in a dose-response manner, with increased severity of each of the three primary symptoms of ASD: social deficits (p = 0.021), communicative impairments (p = 0.030), and repetitive behaviors (p = 0.047). These data indicate that DUF1220 protein domain (CON1) dosage has an ASD-wide effect and, as such, is likely to be a key component of a major pathway underlying ASD severity. Finally, these findings, by implicating the dosage of a previously unexamined, copy number polymorphic and brain evolution-related gene coding sequence in ASD severity, provide an important new direction for further research into the genetic factors underlying ASD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence of Brain Overgrowth in the First Year of Life in Autism
Courchesne, E. (2003) · JAMA · doi:10.1001/jama.290.3.337 · Cited by 1,120
Courchesne, E., & Pierce, K. (2005) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2005.03.001 · Cited by 968 · cited 1×
“process, resulting from (or exacerbated by) CON1 dosage increase, could in turn lead to the excess of localized versus long-distance connectivity seen in individuals with ASD [17].”
BackgroundNeuron Number and Size in Prefrontal Cortex of Children With Autism
Courchesne, E., Mouton, P. R., Calhoun, M. E., Semendeferi, K., Ahrens-Barbeau, C., Hallet, M. J., Barnes, C. C., & Pierce, K. (2011) · JAMA · doi:10.1001/jama.2011.1638 · Cited by 779 · cited 1×
“ASD has been frequently linked to an accelerated postnatal brain growth [2] that likely involves excessive neuron number and increased neuron density [3] which may affect symptom presentation through gray matter and total volumetric increases [4–6].”
BackgroundGenetics of autism spectrum disorders
Geschwind, D. H. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.07.003 · Cited by 696
Sibling Recurrence and the Genetic Epidemiology of Autism
Constantino, J. N., Zhang, Y., Frazier, T., Abbacchi, A. M., & Law, P. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101470 · Cited by 481 · cited 2×
“Simplex and multiplex status was also collected due to previous reports suggesting different symptoms and different etiologies depending on familial status [22].”
BackgroundRojas, D. C., Peterson, E., Winterrowd, E., Reite, M. L., Rogers, S. J., & Tregellas, J. R. (2006) · BMC Psychiatry · doi:10.1186/1471-244x-6-56 · Cited by 360
Schumann, C. M., Barnes, C. C., Lord, C., & Courchesne, E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.007 · Cited by 340
CGG repeat in the FMR1 gene: size matters
Willemsen, R., Levenga, J., & Oostra, B. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01723.x · Cited by 184
Evolution of genetic and genomic features unique to the human lineage
O'Bleness, M., Searles, V. B., Varki, A., Gagneux, P., & Sikela, J. M. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3336 · Cited by 168 · cited 2×
“Also, it is particularly striking that the data presented here, together with our previous findings relating DUF1220 copy number to human brain evolution [10,15,16], imply that both expansion of the human brain and increase in autism severity appear to involve increasing dosage of sequences within the same gene family.”
BackgroundResultSelf-citationChanging the Landscape of Autism Research: The Autism Genetic Resource Exchange
Lajonchere, C. M. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.009 · Cited by 91
Cited by
Evolution of the Human Nervous System Function, Structure, and Development
Sousa, A. M. M., Meyer, K. A., Santpere, G., Gulden, F. O., & Sestan, N. (2017) · Cell · doi:10.1016/j.cell.2017.06.036 · Cited by 517
Autism As a Disorder of High Intelligence
Crespi, B. J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00300 · Cited by 156
“…primates; Dumas et al., 2012; Keeney et al., 2014), (2) IQ and mathematical aptitude (Davis et al., 2015), and (3) the severity of autism (Davis et al., 2014); by contrast, DUF1220 repeat numbers are inversely associated with positive-symptom (though not negative-symptom) severity in…”
BackgroundNeocortical neurogenesis and the etiology of autism spectrum disorder
Packer, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.002 · Cited by 138
Human evolution: the non-coding revolution
Franchini, L. F., & Pollard, K. S. (2017) · BMC Biology · doi:10.1186/s12915-017-0428-9 · Cited by 90
Severity of Autism Spectrum Disorders: Current Conceptualization, and Transition to DSM-5
Mehling, M. H., & Tassé, M. J. (2016) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-016-2731-7 · Cited by 89
Metadata
- Authors
- Davis, J. M., Searles, V. B., Anderson, N., Keeney, J., Dumas, L., & Sikela, J. M.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-03-20
- Volume
- 10
- Issue
- 3
- Pages
- e1004241
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W1996019688
- Cited by
- 51
- References
- 10
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism. https://app.cochat.ai/papers/10.1371/journal.pgen.1004241
- The paper
- Davis, J. M., Searles, V. B., Anderson, N., Keeney, J., Dumas, L., & Sikela, J. M. (2014). DUF1220 Dosage Is Linearly Associated with Increasing Severity of the Three Primary Symptoms of Autism. PLoS Genetics. https://doi.org/10.1371/journal.pgen.1004241
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.